Dimensional Fund Advisors LP Reduces Stake in Humana Inc. $HUM

Dimensional Fund Advisors LP reduced its stake in shares of Humana Inc. (NYSE:HUM – Free Report) by 1.3% during the first quarter, Holdings Channel reports. The firm owned 1,211,874 shares of the insurance provider’s stock after selling 15,985 shares during the quarter. Dimensional Fund Advisors LP’s holdings in Humana were worth $210,024,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently modified their holdings of the company. SEB Asset Management AB bought a new stake in shares of Humana during the 1st quarter valued at about $4,201,000. Swiss National Bank raised its stake in Humana by 7.1% in the first quarter. Swiss National Bank now owns 352,960 shares of the insurance provider’s stock worth $61,200,000 after buying an additional 23,440 shares in the last quarter. Watershed Asset Management L.L.C. purchased a new stake in Humana in the first quarter worth about $474,000. Hartford Funds Management Co LLC purchased a new stake in Humana in the first quarter worth about $419,000. Finally, Calamos Wealth Management LLC bought a new stake in Humana during the 1st quarter valued at approximately $301,000. 92.38% of the stock is owned by hedge funds and other institutional investors.

Get Humana alerts:

Humana Price Performance

HUM opened at $388.56 on Friday. The company’s 50-day simple moving average is $364.10 and its two-hundred day simple moving average is $265.01. The company has a debt-to-equity ratio of 0.66, a quick ratio of 1.77 and a current ratio of 1.77. The stock has a market capitalization of $46.65 billion, a P/E ratio of 41.56, a P/E/G ratio of 2.15 and a beta of 0.71. Humana Inc. has a 52-week low of $163.11 and a 52-week high of $428.88.

Humana (NYSE:HUM – Get Free Report) last issued its quarterly earnings data on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. The company had revenue of $39.65 billion for the quarter, compared to the consensus estimate of $39.37 billion. Humana had a net margin of 0.82% and a return on equity of 10.45%. The firm’s revenue for the quarter was up 23.5% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $11.58 earnings per share. Humana has set its FY 2026 guidance at 9.000- EPS. As a group, analysts predict that Humana Inc. will post 9.46 EPS for the current year.

Analyst Ratings Changes

A number of research firms have recently commented on HUM. Evercore raised their target price on Humana from $250.00 to $370.00 in a research note on Thursday, June 11th. UBS Group reiterated a “neutral” rating on shares of Humana in a report on Monday, June 15th. Deutsche Bank Aktiengesellschaft cut shares of Humana from a “buy” rating to a “hold” rating in a report on Wednesday, May 20th. Seaport Research Partners lowered shares of Humana to a “neutral” rating in a research note on Wednesday, May 20th. Finally, Morgan Stanley lifted their price target on shares of Humana from $217.00 to $249.00 and gave the company an “underweight” rating in a research report on Thursday, June 4th. Two investment analysts have rated the stock with a Strong Buy rating, nine have given a Buy rating, fifteen have given a Hold rating and two have assigned a Sell rating to the stock. Based on data from MarketBeat, the company currently has an average rating of “Hold” and a consensus target price of $327.17.

Check Out Our Latest Research Report on Humana

About Humana

(Free Report)

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.

Recommended Stories

• Five stocks we like better than Humana
• AMD and Cerbras Create A New Blueprint For Hardware
• Intel Earnings Reveal Whether the Chip Selloff Created a Buy
• CrowdStrike’s Cerebras Deal Puts Its AI Security Strategy to the Test
• Plugging In: How Kinder Morgan Powers Up Profits

Want to see what other hedge funds are holding HUM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Humana Inc. (NYSE:HUM – Free Report).

Receive News & Ratings for Humana Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Humana and related companies with MarketBeat.com's FREE daily email newsletter.